Ligand Pharmaceuticals (LGND) Interest Coverage Ratio: History & Chart

Ligand Pharmaceuticals Incorporated(LGND)

Biotechnology · Jupiter, FL

$297.55-9.22 (-3.01%)

Delayed quote: Oct 6, 2026, 12:15 PM EDT

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For hematologic malignancies, these include Kyprolis and Evomela, both targeting multiple myeloma, as well as Rylaze, a treatment for acute lymphoblastic leukemia and lymphoblastic lymphoma in both adult and pediatric patients. In the realm of infectious diseases, Ligand offers Veklury for moderate to severe COVID-19, Vaxneuvance for preventing invasive Streptococcus pneumoniae disease, and Pneumosil, a pneumococcal conjugate vaccine designed to protect children from pneumonia. Bone health solutions comprise Teriparatide injection for osteoporosis and Duavee for postmenopausal osteoporosis. Other key offerings include Zulresso, a Captisol-enabled formulation of brexanolone for postpartum depression; Nexterone, a Captisol-enabled amiodarone; and Noxafil-IV, a Captisol-enabled posaconazole for intravenous administration. The company’s comprehensive product lineup further extends to the Aziyo portfolio, featuring pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune disorders; Vivitra for breast cancer; Bryxta and Zybev for a variety of indications; and Minnebro for managing hypertension. Beyond its own commercialized products, Ligand Pharmaceuticals collaborates with partners on numerous programs currently undergoing clinical development, targeting conditions such as cancer, seizure disorders, diabetes, cardiovascular ailments, muscle wasting, hepatic and renal diseases, and various other serious illnesses. The company also directly supplies Captisol materials, a proprietary technology frequently integrated into many of its drug formulations. Established in 1987, Ligand Pharmaceuticals is headquartered in Emeryville, California.

Jupiter, FL

47 employees

www.ligand.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Todd C. Davis

View full financials

LGND Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

10.01x

INTEREST COVERAGE RATIO AVG TTM

18.75x

INTEREST COVERAGE RATIO AVG 3Y

-3.77x

INTEREST COVERAGE RATIO AVG 5Y

6.75x

INTEREST COVERAGE RATIO AVG 10Y

4.17x

INTEREST COVERAGE RATIO AVG 15Y

3.16x

INTEREST COVERAGE RATIO AVG 20Y

4.04x

CURRENT VS TTM AVG

-46.63%

CURRENT VS 3Y AVG

+365.17%

CURRENT VS 5Y AVG

+48.25%

CURRENT VS 10Y AVG

+140.10%

CURRENT VS 15Y AVG

+216.59%

CURRENT VS 20Y AVG

+147.99%

SECTOR MEDIAN · HEALTHCARE

-5.65x

median of 459 covered companies

CURRENT VS SECTOR MEDIAN

+277.17%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Ligand Pharmaceuticals Incorporated (LGND)	$5.96B	10.01x	18.75x	-3.77x	6.75x
GRAIL Inc. (GRAL)vs ›	$5.98B	N/A	N/A	N/A	N/A
Iovance Biotherapeutics, Inc. (IOVA)vs ›	$5.89B	N/A	N/A	N/A	N/A
Kiniksa Pharmaceuticals International, plc (KNSA)vs ›	$5.77B	N/A	N/A	N/A	N/A
CG Oncology Inc. (CGON)vs ›	$5.73B	N/A	N/A	N/A	N/A
MiniMed Group, Inc. Common Stock (MMED)vs ›	$5.56B	N/A	N/A	N/A	N/A
Rhythm Pharmaceuticals, Inc. (RYTM)vs ›	$6.39B	-9.33x	N/A	N/A	N/A
RadNet, Inc. (RDNT)vs ›	$5.52B	1.30x	1.31x	1.26x	1.25x
Lantheus Holdings, Inc. (LNTH)vs ›	$6.51B	15.74x	19.48x	15.56x	15.56x
Amneal Pharmaceuticals, Inc. (AMRX)vs ›	$6.53B	1.75x	1.35x	1.23x	1.08x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Ligand Pharmaceuticals Incorporated (LGND)

$5.96B

10.01x

18.75x

-3.77x

6.75x

GRAIL Inc. (GRAL)vs ›

$5.98B

N/A

Iovance Biotherapeutics, Inc. (IOVA)vs ›

$5.89B

N/A

Kiniksa Pharmaceuticals International, plc (KNSA)vs ›

$5.77B

N/A

CG Oncology Inc. (CGON)vs ›

$5.73B

N/A

MiniMed Group, Inc. Common Stock (MMED)vs ›

$5.56B

N/A

Rhythm Pharmaceuticals, Inc. (RYTM)vs ›

$6.39B

-9.33x

N/A

RadNet, Inc. (RDNT)vs ›

$5.52B

1.30x

1.31x

1.26x

1.25x

Lantheus Holdings, Inc. (LNTH)vs ›

$6.51B

15.74x

19.48x

15.56x

Amneal Pharmaceuticals, Inc. (AMRX)vs ›

$6.53B

1.75x

1.35x

1.23x

1.08x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The interest coverage ratio for LGND stock is 10.01x.

Is Ligand Pharmaceuticals Incorporated's interest coverage ratio high or low?

The interest coverage ratio of 10.01x is 48% above its 5-year average of 6.75x, near the low end of its 5-year range (-41.77x–3078.00x).

What is the TTM average interest coverage ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The TTM average interest coverage ratio for LGND stock is 18.75x.

What is the 3Y average interest coverage ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The 3Y average interest coverage ratio for LGND stock is -3.77x.

What is the 5Y average interest coverage ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The 5Y average interest coverage ratio for LGND stock is 6.75x.

What is the 10Y average interest coverage ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The 10Y average interest coverage ratio for LGND stock is 4.17x.

What is the 15Y average interest coverage ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The 15Y average interest coverage ratio for LGND stock is 3.16x.

What is the 20Y average interest coverage ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The 20Y average interest coverage ratio for LGND stock is 4.04x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	4.91x
2026-03-31	9.94x
2025-12-31	11.23x
2025-09-30	60.36x
2025-06-30	7.32x
2025-03-31	-41.77x
2024-12-31	-10.91x
2024-09-30	4.24x
2024-06-30	-15.06x
2024-03-31	21.19x
2023-12-31	-25.63x
2023-09-30	3078.00x
2023-06-30	-6.98x
2023-03-31	59.19x
2022-12-31	50.73x
2022-09-30	37.17x
2022-06-30	19.78x
2022-03-31	2.70x
2021-12-31	2.85x
2021-09-30	3.54x
2021-06-30	9.37x
2021-03-31	0.81x
2020-12-31	1.75x
2020-09-30	0.60x
2020-06-30	1.14x
2020-03-31	0.44x
2019-12-31	-1.15x
2019-09-30	-0.57x
2019-06-30	-0.46x
2019-03-31	92.81x
2018-12-31	1.65x
2018-09-30	2.09x
2018-06-30	5.22x
2018-03-31	10.64x
2017-12-31	10.22x
2017-09-30	4.87x
2017-06-30	3.90x
2017-03-31	3.47x
2016-12-31	6.44x
2016-09-30	1.75x
2016-06-30	1.43x
2016-03-31	5.02x
2015-12-31	3.76x
2015-09-30	2.93x
2015-06-30	1.47x
2015-03-31	1.13x
2014-12-31	3.31x
2014-09-30	2.33x
2014-06-30	7.50x
2014-03-31	20.56x
2013-12-31	19.95x
2013-09-30	7.79x
2013-06-30	3.34x
2013-03-31	4.31x
2012-12-31	5.20x
2012-09-30	-1.80x
2012-06-30	-2.04x
2012-03-31	-0.97x
2011-12-31	8.01x
2011-09-30	-4.86x
2011-06-30	-1.20x
2011-03-31	-5.24x
2010-12-31	-313.79x
2010-09-30	-1959.38x
2010-06-30	-279.08x
2010-03-31	-223.67x
2009-12-31	96.54x
2009-09-30	36.86x
2009-06-30	-110.88x
2009-03-31	-37.72x
2008-03-31	-228.83x

DATE

INTEREST COVERAGE RATIO

2026-06-30

4.91x

2026-03-31

9.94x

2025-12-31

11.23x

2025-09-30

60.36x

2025-06-30

7.32x

2025-03-31

-41.77x

2024-12-31

-10.91x

2024-09-30

4.24x

2024-06-30

-15.06x

2024-03-31

21.19x

2023-12-31

-25.63x

2023-09-30

3078.00x

2023-06-30

-6.98x

2023-03-31

59.19x

2022-12-31

50.73x

2022-09-30

37.17x

2022-06-30

19.78x

2022-03-31

2.70x

2021-12-31

2.85x

2021-09-30

3.54x

2021-06-30

9.37x

2021-03-31

0.81x

2020-12-31

1.75x

2020-09-30

0.60x

2020-06-30

1.14x

2020-03-31

0.44x

2019-12-31

-1.15x

2019-09-30

-0.57x

2019-06-30

-0.46x

2019-03-31

92.81x

2018-12-31

1.65x

2018-09-30

2.09x

2018-06-30

5.22x

2018-03-31

10.64x

2017-12-31

10.22x

2017-09-30

4.87x

2017-06-30

3.90x

2017-03-31

3.47x

2016-12-31

6.44x

2016-09-30

1.75x

2016-06-30

1.43x

2016-03-31

5.02x

2015-12-31

3.76x

2015-09-30

2.93x

2015-06-30

1.47x

2015-03-31

1.13x

2014-12-31

3.31x

2014-09-30

2.33x

2014-06-30

7.50x

2014-03-31

20.56x

2013-12-31

19.95x

2013-09-30

7.79x

2013-06-30

3.34x

2013-03-31

4.31x

2012-12-31

5.20x

2012-09-30

-1.80x

2012-06-30

-2.04x

2012-03-31

-0.97x

2011-12-31

8.01x

2011-09-30

-4.86x

2011-06-30

-1.20x

2011-03-31

-5.24x

2010-12-31

-313.79x

2010-09-30

-1959.38x

2010-06-30

-279.08x

2010-03-31

-223.67x

2009-12-31

96.54x

2009-09-30

36.86x

2009-06-30

-110.88x

2009-03-31

-37.72x

2008-03-31

-228.83x

Interest Coverage Ratio: 10.01x

LGND Interest Coverage Ratio

LGND Average Interest Coverage Ratio Chart

LGND Current vs Average Interest Coverage Ratio Chart

LGND Interest Coverage Ratio Metrics

LGND Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

LGND Interest Coverage Ratio History

Related Metrics